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a b s t r a c t
Two distinct antigenic clusters were previously identiﬁed among the H3N2 swine inﬂuenza A viruses
(IAVs) and were designated H3N2SIV-alpha and H3N2SIV-beta (Feng et al., 2013. Journal of Virology 87
(13), 7655–7667). A consistent mutation was observed at the position 189 of hemagglutinin (R189K)
between H3N2SIV-alpha and H3N2SIV-beta fair isolates. To evaluate the contribution of R189K mutation
to the antigenic drift from H3N2SIV-alpha to H3N2SIV-beta, four reassortant viruses with 189R or 189K
were generated. The antigenic cartography demonstrated that the R189K mutation in the hemagglutinin
of H3N2 IAV contributed to the antigenic drift, separating these viruses into H3N2SIV-alpha to H3N2SIV-
beta. This R189K mutation was also found to contribute to the cross-reaction with several ferret sera
raised against historical human IAVs with hemagglutinin carrying 189K. This study suggests that the
R189K mutation plays a vital role in the antigenicity of swine and human H3N2 IAVs and identiﬁcation of
this antigenic determinant will help us rapidly identify antigenic variants in inﬂuenza surveillance.
& 2013 Elsevier Inc. All rights reserved.
Introduction
Inﬂuenza A viruses (IAVs) belong to the family Orthomyxovir-
idae. Among the 17 HA subtypes of IAVs identiﬁed, H3 is one of the
most widely circulating subtypes in nature. H3 IAVs have been
recovered from humans, pigs, horses, dogs, birds, and seals. H3
IAVs caused the 1968 pandemic (by H3N2 IAV), contemporary
seasonal epidemics (H3N2) in humans, epidemic or endemic
diseases in pigs (H3N2) (Zhou et al., 1999, 2000), horses (H3N8)
(Thomson et al., 1977), and dogs (H3N2 and H3N8) (Crawford
et al., 2005; Li et al., 2010; Song et al., 2008; Yoon et al., 2005).
In the North American swine population, the current predomi-
nant H3N2 IAV was associated with a “spillover” of human
seasonal H3N2 IAVs to pigs in 1990′s (Vincent et al., 2008; Zhou
et al., 1999). Phylogenetic analyses of HA genes of H3N2 SIVs in
North America demonstrated that there have been at least four
genetic groups (Cluster I–IV) (Olsen et al., 2006), and H3N2 IAVs of
Cluster IV has predominated in US swine populations since 2005
(Hause et al., 2010). Neutralization assay using swine antisera
demonstrated that these four genetic clusters are also antigeni-
cally distinct, varying from a 2 to 8-fold change in hemagglutina-
tion inhibition (HI) titers, although cross reaction exists among
these clusters to a degree (Hause et al., 2010).
In 2011, a novel IAV, so called H3N2 variant (H3N2v), was
identiﬁed in agricultural fairs. This virus caused more than 325
conﬁrmed human inﬂuenza cases in 14 states (CDC, 2012a, 2012b;
Lindstrom et al., 2012). Genetically, the hemagglutinin gene of
H3N2v-like IAV belongs to Cluster IV of H3N2 SIVs. Recently,
antigenic proﬁle of four human H3N2v isolates, 12 commercial
swine farm isolates, and 68 isolates recovered from pigs at 2009–
2011 Ohio county fairs were characterized in our laboratory (Feng
et al., 2013). These 84 isolates were clearly divided into two
antigenic clusters, H3N2SIV-alpha and H3N2SIV-beta. The human
H3N2v isolates were grouped with H3N2 SIV-beta while the swine
isolates were divided between two antigenic clusters. Sequence
analysis of these isolates showed a number of variations at anti-
body binding sites among these H3N2 isolates, but only the
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mutation arginine (R) to lysine (K) at the position 189 of hemag-
glutinin was consistent between H3N2SIV-alpha and H3N2SIV-
beta. Also, our previous study showed that the viruses in the
antigenic cluster H3N2SIV-beta cross-reacted with ferret antisera
produced against several seasonal human inﬂuenza viruses (Feng
et al., 2013). Interestingly, these human seasonal viruses also
carried 189K in HA.
In this study, four reassortants with 189R or 189K were
generated by reverse genetics, and serological assays were con-
ducted for these reassortants to determine if the R189K mutation
drives the antigenic drift of these H3N2 SIVs. In addition, this study
was conducted to determine if the R189K mutation contributes to
the cross-reaction to sera against human seasonal viruses.
Results and discussion
To evaluate contribution of R189K mutation to antigenic drift
of H3N2 IAVs from Ohio county fairs, four reassortant viruses were
generated by reverse genetics and designated as 09SW64_189R (wt),
09SW64_189K (mt), 11SW347_189K (wt) and 11SW347_189R (mt)
(Table 1). The 09SW64_189R (wt) represented an IAV in the antigenic
cluster H3N2SIV-alpha whereas 11SW347_189K (wt) represented an
IAV in the antigenic cluster H3N2SIV-beta. The HI results showed
that the antisera against H3N2SIV-alpha isolates had a HI titer of
1280 to 2560 against 09SW64_189R (wt) whereas the antisera
against H3N2SIV-beta isolates had a HI of 40–80 against
09SW64_189R (wt). In contrast, the antisera against H3N2SIV-beta
isolates had a HI titer of 480–960 against 11SW347_189K (wt)
whereas the antisera against H3N2SIV-alpha isolates had a HI
of 10–20 against 11SW347_189K (wt). The antigenic proﬁle of
these two reassortant viruses resembled their wild type isolates (A/
swine/Ohio/09SW64/2009(H3N2) and A/swine/Ohio/11SW347/2011
(H3N2), respectively. Antigenic cartography conﬁrmed each of these
two reassortant viruses was located in the corresponding antigenic
cluster: 09SW64_189R (wt) belonged to H3N2SIV-alpha whereas
11SW347_189K (wt) was clustered to H3N2SIV-beta (Fig. 1).
The antisera against H3N2SIV-alpha isolates had HI titers ranging
from 640 to 1280 to 09SW64_189K (mt), and these HI titers were
two folds lower than those HI titers for the same set of antisera to
09SW64_189R (wt); the antisera against H3N2SIV-beta isolates had
HI titers ranging from 240 to 320 to 09SW64_189K (mt), and these HI
titers were at least four-fold higher than those HI titers for the same
set of antisera against 09SW64_189R (wt) (Table 1). On the other
hand, the antisera against H3N2SIV-alpha isolates had HI titers
ranging from 20 to 80 to 11SW347_189R (mt), and these HI titers
were at least two folds higher than those HI titers for the same set of
antisera to 11SW347_189K (wt); the antisera against H3N2SIV-beta
isolates had HI titers ranging from 120 to 320 to 11SW347_189R (mt),
and these HI titers were at least three folds lower than those HI titers
for the same set of antisera to 11SW347_189K (wt). These HI data
demonstrate that the R189K mutation in the hemagglutinin of H3N2
IAV contributed to the antigenic drift. Antigenic cartography demon-
strated that the R189K mutation could move A/swine/09SW64/2009
(H3N2) from antigenic cluster H3N2SIV-alpha forward to antigenic
cluster H3N2SIV-beta whereas the K189R mutation could drive
A/swine/11SW347/2011(H3N2) from antigenic cluster H3N2SIV-
beta toward antigenic cluster H3N2SIV-alpha (Fig. 1).
In this study, we also produced ferret antisera against the two
mutant strains 09SW64_189K and 11SW347_189R. The HI assay
demonstrated the antisera against 09SW64_189K showed 2-fold
higher HI titer for 11SW347_189K than 11SW347_189R, and the
antisera against 11SW347_189R had 4-fold higher HI titer for
09SW64_189R than 09SW64_189K (Table 1). This data further
supported our conclusion that the single R189K mutation in the
HA of swine H3N2 IAV contributed to the antigenic drift, separat-
ing these viruses into H3N2SIV-alpha to H3N2SIV-beta.
Our results also suggested that the changes in heterologous titers
were more than homologous titers. For example, the changes in
11SW347_189K and 11SW347_189R against their corresponding
antibody were about two fold, whereas those in 10SW215 against
11SW347_189K and 11SW347_189R ferret antisera were four fold.
This indicated that some other mutations (not in reported antibody
binding sites of H3N2 IAVs(Wilson and Cox, 1990)) in HA, NA, or MP
protein might affect inﬂuenza antigenicity indirectly, although R189K
is the predominant mutation leading to antigenic drift in H3N2 SIVs.
Our previous study showed that the viruses in the antigenic
cluster H3N2SIV-beta cross-reacted with ferret antisera produced
against three seasonal human inﬂuenza viruses, including A/Caen/
1/1984(H3N2), A/Ann Arbor/03/1993(H3N2), and A/Nanchang/
933/1995(H3N2). Among these, the ferret antiserum against
A/Caen/1/1984(H3N2) exhibited the highest HI titer, 1:160, to the
viruses in the antigenic cluster H3N2SIV-beta whereas the ferret
antiserum against A/Caen/1/1984(H3N2) does not have any cross
reactions against the viruses in the antigenic cluster H3N2SIV-
alpha (Feng et al., 2013). Sequence analysis showed that hemag-
glutinin of A/Caen/1/1984(H3N2) also carried 189K, like the
hemagglutinin of IAV in the antigenic cluster H3N2SIV-beta. To
evaluate the contribution of the R189K mutation in that cross-
reaction, HI assay was performed on the four reassortant viruses
using antisera produced against several historic seasonal human
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Fig. 1. Antigenic cartography was constructed using HI data for 68 SIV isolates from
Ohio agricultural fairs (2009–2011),12 SIV isolates from commercial farms (2006–
2012), and four human H3N2v inﬂuenza virus isolates, and four reassortant viruses
(09SW64_189R, 09SW64_189K, 11SW347_189R, and 11SW347_189K). The HI data
for 80 SIV isolates and four human H3N2v isolates were adapted from (Feng et al.,
2013), and those for four reassortant viruses were shown in Table 1. Antigenic
clusters H3N2SIV-alpha and H3N2SIV-beta and the viruses in each clusters were
described in (Feng et al., 2013). 09SW64 and the corresponding reassortants
(09SW64_189R and 09SW64_189K) were marked in blue whereas 11SW347 and
the corresponding reassortants (11SW347_189R and 11SW347_189K) in pink.
This cartography demonstrates that R189K moves 09SW64 from antigenic cluster
H3N2SIV-alpha towards H3N2SIV-beta and that K189R moves 11SW347 from
antigenic cluster H3N2SIV-beta towards H3N2SIV-alpha. Antigenic cartography
was constructed using AntigenMap (http://sysbio.cvm.msstate.edu/AntigenMap)
(Barnett et al., 2012; Cai et al., 2010).
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inﬂuenza virus strains with or without 189K. As described in
Table 2, the HI titers for the ferret antisera against A/Caen/1/1984
(H3N2), A/Mississippi/1/1985(H3N2), and A/Leningrad/360/1986
(H3N2), all of which had 189K, had higher HI titers to those
reassortant viruses carrying 189K than to those carrying 189R.
Although the ferret antiserum against A/Philippines/2/1982
(H3N2) did not show cross reaction with 09SW64_189K, this
serum had a titer of 20 against 11SW347_189K but did not cross
react with 11SW347_189R. These results suggest that position 189
would be an important antibody binding site, as is consistent with
previous antigenic analysis of human seasonal H3N2 IAV (Huang
et al., 2009; Smith et al., 2004). It was recently reported that
K189N/D/Q/E mutations were involved in the antigenic drift of
horse H3N8 isolates collected between 1968 and 2007 (Lewis
et al., 2011). These observations further highlight the important
role of amino acid at position 189 in the antigenicity of H3 IAVs.
Compared with those isolates in antigenic cluster H3N2SIV_al-
pha, the H3N2 swine inﬂuenza isolates in H3N2SIV_beta have two
major differences: (1) the introduction of matrix gene from 2009
H1N1 inﬂuenza A virus; (2) a consistent mutation R189K, which is
located in the 190-loop of receptor binding site in H3 subtype of
inﬂuenza A virus. Previous study demonstrated that introduction of
M gene from 2009 pandemic virus increased viral transmissibility
in ferrets (Pearce et al., 2012). However, the R189K seemed not to
affect much receptor binding proﬁles based on the results on
six glycans (Neu5Acα2–3Galβ1–4GlcNAcβ1-; Neu5Acα2–6Galβ1–
4GlcNAcβ1-; Neu5Acα2–3Galβ1–4GlcNAcβ1–3Galβ1–4GlcNAcβ1-;
Neu5Acα2–6Galβ1–4GlcNAcβ1–3Galβ1–4GlcNAcβ1-; and Neu5Acα2–
3Galβ1–4GlcNAcβ1–3Galβ1–4GlcNAcβ1–3Galβ1–4GlcNAcβ1-) (Pearce
et al., 2012). Because these glycans might not represent the entire
glycan proﬁle in human respiratory system, it would be interesting
to characterize the role of R189K in transmission of H3N2v from
swine to human.
To reduce the risks of human infection of H3N2v virus, one
option is to vaccinate these pigs to reduce their viral shedding
before sending them to county fairs. Thus, it will be critical to
perform inﬂuenza surveillance and understand both antigenic and
genetic dynamics of these viruses in the county fair pigs as well as
those pigs to be deployed to county fairs. Identiﬁcation of
antigenic variants is one of the keys to a successful vaccination
program. This study suggested that 189K be an important biomar-
ker for the viruses in H3N2SIV_beta. The viruses in H3N2SIV_beta
are predominant in county fairs and antigenically similar to
human H3N2v isolates but different from the viruses in H3N2SI-
V_alpha, which are also circulating in swine population (Feng
et al., 2013).
Conclusions
In summary, we experimentally demonstrated that a single
mutation (i.e., R189K) in hemagglutinin contributed to the anti-
genic drift of contemporary H3N2 SIVs. To our knowledge, it is the
ﬁrst study to demonstrate contribution of R189K mutation to
antigenic drift among swine H3N2 isolates. Identiﬁcation of this
antigenic determinant will help us rapidly identify antigenic
variants in inﬂuenza surveillance, especially those with an anti-
genic proﬁle similar to the emerging human H3N2v IAVs.
Materials and methods
Cells and viruses
Madin-Darby Canine Kidney cells (MDCK) and human embryo-
nic kidney cells (293T) were purchased from American Type
Culture Collection (ATCC, Manassas, VA). Both cells were main-
tained in Dulbecco′s Modiﬁed Eagle Medium (DMEM) (GIBCO/BRL,
Grand Island, NY), supplemented with 5% fetal bovine serum (FBS)
(Atlanta Biologicals, Lawrenceville, GA), penicillin–streptomycin,
and amphotericin B (GIBCO/BRL, Grand Island, NY), at 37 1C with
5% CO2. All the viruses generated by reverse genetics were
propagated in MDCK cells cultured in Opti-MEM medium
(GIBCO/BRL, Grand Island, NY) supplemented with 1 μg/ml TPCK-
Trypsin (Sigma-Aldrich, St. Louis, MO), penicillin–streptomycin,
and amphotericin B (GIBCO/BRL, Grand Island, NY), at 37 1C with
5% CO2.
Plasmids and site directed mutagenesis
The eight gene segments of PR8 were kindly provided by
Dr. Richard Webby at St. Jude Children′s Research Hospital.
The hemagglutinin gene of A/swine/Ohio/09SW0964/2009
(H3N2) (09SW64) (GenBank accession number: CY130717.1) and
A/swine/Ohio/11SW347/2011(H3N2) (11SW347) (GenBank acces-
sion number: CY131957.1) and the neuraminidase gene from A/
Sydney/05/1997 (H3N2) (SY97) were cloned into pHW2000 vector
as described elsewhere (Cai et al., 2012). The R189K in hemagglu-
tinin of 09SW64 and K189R in hemagglutinin of 11SW347 were
introduced using the QuickChange II site-directed mutagenesis kit
(Stratagene, Inc., La Jolla, CA) according to manufacturer′s proto-
cols. The presence of the corresponding mutation (without any
other unintended mutations) was conﬁrmed by sequencing.
Generation of reassortant viruses by reverse genetics
The reassortant viruses were recovered by transfection in co-
cultured 293T and MDCK cells in 6-well plates. Brieﬂy, 1 μg of each
of six plasmids, each of which carries one of six PR8 internal gene
(polymerase PB1, polymerase PA, polymerase PB2, nucleoprotein
gene, matrix gene, or nonstructural gene), were mixed with 1 μg
of SY97 neuraminidase plus 1 μg of 09SW64, 11SW347, 09SW64-
189K, or 11SW347-189R hemagglutinin gene in 234 μl Opti-MEM
medium. Then, 16 μl of TransITs-LT1 Transfection Reagent (Mirus
Bio LLC, Madison, WI) was added into the mixture. The mixture
was incubated at ambient temperature for 45 min, and then 800 μl
of Opti-MEM medium was added and mixed. The mixture was
then added to the co-cultured 293T and MDCK cells in 6-well
plates. Twelve hours post transfection, the medium was changed
with 2 ml of fresh Opti-MEM medium with 1 μg/ml TPCK-Trypsin
(Sigma-Aldrich, St. Louis, MO). At day 3 post transfection, a half of
the medium plus cells were inoculated into MDCK cell. Ninety-six
hours post inoculation, the supernatant from the infected cells
was collected and stored in 80 1C until use. As a result, four
6+2 reassortants were generated, so called 09SW64_189R,
09SW64_189K, 11SW347_189K and 11SW347_189R (Table 1).
Genomic sequencing
The vRNA and cDNA were prepared as previously described (Ye
et al., 2010). Eight fragments were ampliﬁed and sequenced using
a combination of universal and custom made primers (available
upon request) (Hoffmann et al., 2001). Sequencing was performed
by Life Sciences Core Laboratories Center at Cornell University
using the Applied Biosystems Automated 3730 DNA Analyzer,
which utilized Big Dye Terminator chemistry and AmpliTaq-FS
DNA Polymerase.
Generation of ferret antisera
Ferret antisera were generated in 6- to 8-week-old ferrets, which
had baseline HI titers less than 1:10 against A/Brisbane/10/2007
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(H3N2), A/Brisbane/59/2007(H1N1), and A/California/4/2009(H1N1).
Each ferret was inoculated intranasally with 106 TCID50 for mutant
strain 09SW64_189K and 11SW347_189R respectively according to
protocol IACUC-11-027 and IBC-011-11 approved by Ofﬁce of Regula-
tory Compliance Institutional Biosafety Committee and Institutional
Animal Care and Use Committee from Mississippi State University.
Sera were collected from the ferrets at three weeks post inoculation if
the HI titer in a ferret was at least 1:160 at 2 weeks post inoculation.
Otherwise, a second dose of 106 TCID50 of the corresponding virus was
given and serum was collected ﬁve weeks post ﬁrst inoculation. All
sera were aliquoted and stored at 701 C until use.
In addition to the above two ferret sera, this study also included
seven ferret antisera prepared against two H3N2 isolates in
antigenic cluster H3N2SIV-alpha, A/swine/Ohio/09SW64/2009
(H3N2) and A/swine/Ohio/09SW96/2009(H3N2) and ﬁve isolates
in antigenic cluster H3N2SIV-beta, A/swine/Ohio/10SW130/2010
(H3N2), A/swine/Ohio/10SW156/2010(H3N2), A/swine/Ohio/
10SW215/2010(H3N2), A/swine/Ohio/11SW208/2011(H3N2) and
A/swine/Ohio/11SW347/2011(H3N2). The generation of these
sera was described in (Feng et al., 2013). In addition, nine ferret
sera against human seasonal inﬂuenza viruses, A/Philippine/2/
82 (H3N2), A/Caen/1/1984(H3N2), A/Mississippi/1/1985(H3N2),
A/Leningrad/360/1986(H3N2), A/Sichuan/60/1989 (H3N2), A/Ann
Arbor/03/1993 (H3N2), A/Johannesburg/33/1994 (H3N2), A/Nan-
chang/933/1995 (H3N2), and A/Sydney/05/1997 (H3N2) were
also included, and the generation of these sera were described in
(Sun et al. 2013). These sera are listed in Tables 1 and 2.
Hemagglutination (HA) and HI assays
Virus HA titers were measured using 0.5% turkey red blood cells
according to the World Health Organization (WHO) Manual on
Animal Inﬂuenza Diagnosis and Surveillance (http://www.who.int/
csr/resources/publications/inﬂuenza/whocdscsrncs20025rev.pdf).
In the HI assays, the antisera against different viruses listed in
Tables 1 and 2 were ﬁrst treated with receptor-destroying enzyme
(RDE) (Denka Seiken Co., Tokyo, Japan) in 1:3 (volume of serum:
volume of RDE) at 37 1C for 18 h, and then heat inactivated at 56 1C
for 30 min. The sera were then diluted with phosphate-buffered
saline (for a ﬁnal dilution of 1:10). The anti-viral antibody titers
were assessed using the HI assay outlined by the WHO Manual on
Animal Inﬂuenza Diagnosis and Surveillance. Each HI was repeated
at least three times, and the average value was documented
(Tables 1 and 2).
Table 1
Antigenic characterization of H3N2 reassortant viruses using hemagglutination inhibition assay against ferret antisera for H3N2 swine inﬂuenza viruses.
Virusa Antigenic
clusterd
Ferret antiseraf
09SW64
(189R)e
09SW64c
(189K)
09SW96
(189R)
10SW130
(189K)
10SW156
(189K)
10SW215
(189K)
11SW208
(189K)
11SW347
(189K)
11SW347c
(189R)
09SW64b H3N2SIV-
alpha
2560 1280 1280 80 80 80 60 40 320
09SW64_189R
(wt)c
2560 1920 1280 80 80 80 80 40 480
09SW64_189Kc 1280 1920 640 320 320 320 320 240 120
11SW347b H3N2SIV-
beta
20 NDg 10 320 480 480 1280 960 ND
11SW347_189K
(wt)c
20 80 o10 480 480 640 960 640 640
11SW347_189Rc 80 40 20 120 120 120 320 240 1280
a 09SW64, A/swine/Ohio/09SW0964/2009(H3N2); 09SW96, A/swine/Ohio/09SW96/2009(H3N2); 10SW130, A/swine/Ohio/10SW130/2010(H3N2); 10SW156, A/swine/
Ohio/10SW156/2010(H3N2); 10SW215, A/swine/Ohio/10SW215/2010(H3N2); 11SW208, A/swine/Ohio/11SW208/2011(H3N2); 11SW347, A/swine/Ohio/11SW347/2011(H3N2).
b 09SW64 and 11SW347 are wild type strains used to generate reassortant viruses.
c Reassortant viruses with HA gene from either 09SW64 or 11SW347, NA gene from A/Sydney/05/1997 (H3N2), and six internal genes from A/PR/8/1934(H1N1).
d Antigenic clusters were deﬁned by antigenic cartography using k-mean clustering method in (Feng et al., 2013).
e The amino acid at the position 189 of hemagglutinin of the corresponding virus.
f The number in bold is the homologous HI title.
g ND, not done.
Table 2
Antigenic characterization of H3N2 reassortant viruses using hemagglutination inhibition assay against ferret antisera for human seasonal inﬂuenza A viruses.
Virusa Ferret antisera
PH82 (189K)d CE84 (189K) MS85 (189K) LG86 (189K) SC89 (189R) AN93 (189S) JO94 (189S) NC95 (189S) SY97 (189S)
09SW64b o10 20 o10 o10 o10 20 10 20 o10
09SW64_189R(wt)c o10 o10 o10 o10 o10 20 o10 20 o10
09SW64_189Kc o10 160 40 10 o10 20 o10 20 o10
11SW347b 10 80 10 10 10 40 o10 10 o10
11SW347_189K(wt)c 20 160 20 10 10 20 o10 o10 o10
11SW347_189Rc o10 40 o10 o10 10 20 o10 o10 o10
a 09SW64, A/swine/Ohio/09SW0964/2009(H3N2); 09SW96, A/swine/Ohio/09SW96/2009(H3N2); 11SW347, A/swine/Ohio/11SW347/2011(H3N2); PH82, A/Philippine/2/
82 (H3N2); CE84, A/Caen/1/1984(H3N2); MS85, A/Mississippi/1/1985(H3N2); LG86, A/Leningrad/360/1986(H3N2); SC89,A/Sichuan/60/1989 (H3N2); AN93, A/Ann Arbor/03/
1993 (H3N2); JO94, A/Johannesburg/33/1994 (H3N2); NC95, A/Nanchang/933/1995 (H3N2); SY97, A/Sydney/05/1997 (H3N2).
b 09SW64 and 11SW347 are wild type strains used to generate reassortant viruses.
c Reassortant viruses with HA gene from either 09SW64 or 11SW347, NA gene from A/Sydney/05/1997 (H3N2), and six internal genes from A/PR/8/1934(H1N1).
d The amino acid at the position 189 of hemagglutinin of the corresponding virus.
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Antigenic cartography
Antigenic mapping presents an intuitive way to visualize the
antigenic relationship embedded in serological data by projecting
antigens into a two or three dimensional map, and a larger
antigenic discrepancy in serological data will be reﬂected as a
larger distance in antigenic map (Cai et al., 2010, 2011). In this
study, the antigenic map was generated based on HI data from 88
SIVs (68 fair SIV isolates, 4 human H3N2v isolates, 12 farm SIV
isolates, and 4 reassortant viruses generated in this study) versus
seven reference ferret antisera using AntigenMap by setting HI
titers of 10 or less as low reactors (Barnett et al., 2012; Cai et al.,
2010). Those HI data for 68 fair SIV isolates, 4 human H3N2v
isolates, and 12 farm SIV isolates were adapted from (Feng et al.,
2013). Data normalization was performed as described elsewhere
(Cai et al., 2012).
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